Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia

This study aimed to assess the immune response in infants who received the three-shot hepatitis B vaccine in Malaysia. Consecutive infants born between March 2002 and April 2010 who received three doses of hepatitis B vaccine at a community clinic in Malaysia were enrolled in the study. Screening fo...

Full description

Bibliographic Details
Main Authors: Lee, W.S., Cheang, H.K., Wong, H.T., Ho, S.C., Chew, K.S.
Format: Article
Language:English
Published: Stamford Publishing Pte Ltd 2013
Subjects:
Online Access:http://eprints.um.edu.my/10533/1/Immune_response_in_infants_after_universal_hepatitis_B.pdf
_version_ 1825719875111223296
author Lee, W.S.
Cheang, H.K.
Wong, H.T.
Ho, S.C.
Chew, K.S.
author_facet Lee, W.S.
Cheang, H.K.
Wong, H.T.
Ho, S.C.
Chew, K.S.
author_sort Lee, W.S.
collection UM
description This study aimed to assess the immune response in infants who received the three-shot hepatitis B vaccine in Malaysia. Consecutive infants born between March 2002 and April 2010 who received three doses of hepatitis B vaccine at a community clinic in Malaysia were enrolled in the study. Screening for hepatitis B surface antigen (HBsAg) and antibody against HBsAg (anti-HBs) was performed after the completion of primary immunisation, at approximately one year of age. A total of 572 infants (median age 9.3 ± 2.7 months; range 6.3–48 months) were screened for immune response to hepatitis B vaccination – 553 (96.7%) infants had adequate levels of anti-HBs (≥ 10 IU/L). Of the 440 mothers whose HBsAg status was known, 14 (3.2%) were positive for HBsAg. None of the 14 infants who were born to HBsAg-positive mothers were positive for HBsAg, and all but one infant had anti-HBs level ≥ 10 IU/L. Gender, gestational age and maternal HBsAg status were not found to significantly affect the subsequent immune response in infants following vaccination. The proportion of Malaysian mothers who are positive for HBsAg remains high. The three-shot hepatitis B vaccine, given as part of universal vaccination against hepatitis B, provides adequate anti-HBs in the vast majority of infants in a community setting in Malaysia.
first_indexed 2024-03-06T05:26:24Z
format Article
id um.eprints-10533
institution Universiti Malaya
language English
last_indexed 2024-03-06T05:26:24Z
publishDate 2013
publisher Stamford Publishing Pte Ltd
record_format dspace
spelling um.eprints-105332014-10-14T03:23:22Z http://eprints.um.edu.my/10533/ Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia Lee, W.S. Cheang, H.K. Wong, H.T. Ho, S.C. Chew, K.S. RJ Pediatrics This study aimed to assess the immune response in infants who received the three-shot hepatitis B vaccine in Malaysia. Consecutive infants born between March 2002 and April 2010 who received three doses of hepatitis B vaccine at a community clinic in Malaysia were enrolled in the study. Screening for hepatitis B surface antigen (HBsAg) and antibody against HBsAg (anti-HBs) was performed after the completion of primary immunisation, at approximately one year of age. A total of 572 infants (median age 9.3 ± 2.7 months; range 6.3–48 months) were screened for immune response to hepatitis B vaccination – 553 (96.7%) infants had adequate levels of anti-HBs (≥ 10 IU/L). Of the 440 mothers whose HBsAg status was known, 14 (3.2%) were positive for HBsAg. None of the 14 infants who were born to HBsAg-positive mothers were positive for HBsAg, and all but one infant had anti-HBs level ≥ 10 IU/L. Gender, gestational age and maternal HBsAg status were not found to significantly affect the subsequent immune response in infants following vaccination. The proportion of Malaysian mothers who are positive for HBsAg remains high. The three-shot hepatitis B vaccine, given as part of universal vaccination against hepatitis B, provides adequate anti-HBs in the vast majority of infants in a community setting in Malaysia. Stamford Publishing Pte Ltd 2013 Article PeerReviewed application/pdf en http://eprints.um.edu.my/10533/1/Immune_response_in_infants_after_universal_hepatitis_B.pdf Lee, W.S. and Cheang, H.K. and Wong, H.T. and Ho, S.C. and Chew, K.S. (2013) Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia. Singapore Medical Journal, 54 (4). pp. 224-226. ISSN 0037-5675, DOI https://doi.org/10.11622/smedj.2013078 <https://doi.org/10.11622/smedj.2013078>. doi: 10.11622/smedj.2013078
spellingShingle RJ Pediatrics
Lee, W.S.
Cheang, H.K.
Wong, H.T.
Ho, S.C.
Chew, K.S.
Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia
title Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia
title_full Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia
title_fullStr Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia
title_full_unstemmed Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia
title_short Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia
title_sort immune response in infants after universal hepatitis b vaccination a community based study in malaysia
topic RJ Pediatrics
url http://eprints.um.edu.my/10533/1/Immune_response_in_infants_after_universal_hepatitis_B.pdf
work_keys_str_mv AT leews immuneresponseininfantsafteruniversalhepatitisbvaccinationacommunitybasedstudyinmalaysia
AT cheanghk immuneresponseininfantsafteruniversalhepatitisbvaccinationacommunitybasedstudyinmalaysia
AT wonght immuneresponseininfantsafteruniversalhepatitisbvaccinationacommunitybasedstudyinmalaysia
AT hosc immuneresponseininfantsafteruniversalhepatitisbvaccinationacommunitybasedstudyinmalaysia
AT chewks immuneresponseininfantsafteruniversalhepatitisbvaccinationacommunitybasedstudyinmalaysia